查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2040440

寡核苷酸合成試劑市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測（2026-2033 年）

Oligonucleotide Synthesis Reagents Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

寡核苷酸合成試劑市場概述

全球寡核苷酸合成試劑市場預計到 2025 年將價值 7.233 億美元，預計到 2033 年將達到 17.513 億美元，2026 年至 2033 年的複合年成長率為 11.9%。

這一成長是由對基於寡核苷酸的療法的需求不斷成長、在診斷和基因組學領域的應用不斷擴大以及 DNA/RNA 合成技術的進步所推動的。

核酸療法的快速發展

核酸療法的快速發展是寡核苷酸合成試劑市場的主要驅動力。這是因為這些治療方法以合成寡核苷酸為核心成分。諸如siRNA、反義寡核苷酸（ASO）、基於CRISPR的基因編輯和mRNA平台等治療方法正日益針對以往難以治療的通路，並且在腫瘤學、罕見遺傳病和感染疾病領域已有多種已通過核准治療方法，且開發平臺也在不斷擴展。這種擴張推動了對高品質寡核苷酸的需求，導致從研發到商業化階段合成試劑的消耗量增加。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：寡核苷酸合成試劑市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 案例研究見解
  • 氧化物合成試劑市場分析工具

第4章 寡核苷酸合成試劑市場：產品特定估算與趨勢分析

  • 全球寡核苷酸合成試劑市場：基於產品的波動分析
  • 全球寡核苷酸合成試劑市場：產品規模及趨勢分析（2021-2033年）
  • 主要合成試劑
  • 製程試劑
  • 修飾試劑
  • 純化相關試劑
  • 其他

第5章：寡核苷酸合成試劑市場：按應用分類的估算與趨勢分析

  • 全球寡核苷酸合成試劑市場：基於應用的波動分析
  • 全球寡核苷酸合成試劑市場：按應用領域分類的規模和趨勢分析（2021-2033年）
  • PCR引子
  • PCR檢測與試劑盒
  • 定序
  • DNA微陣列
  • 螢光原位雜合反應（FISH）
  • 反義寡核苷酸
  • 其他用途

第6章 寡核苷酸合成試劑市場：依最終用途分類的估算與趨勢分析

  • 全球寡核苷酸合成試劑市場：依最終用途分類的波動分析
  • 全球寡核苷酸合成試劑市場：依最終用途分類的規模和趨勢分析（2021-2033年）
  • 學術研究機構
  • 診斷檢查室
  • 製藥和生物技術公司

第7章 寡核苷酸合成試劑市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 2025年公司市場分析
  • 公司簡介列表
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Danaher Corporation
    • Tokyo Chemical Industry Pvt. Ltd.
    • Agilent Technologies, Inc.
    • Bio-Synthesis, Inc.
    • Kaneka Eurogentec SA
    • LGC Biosearch Technologies
    • Biolegio
    • Twist Bioscience
Product Code: GVR-4-68040-904-2

Oligonucleotide Synthesis Reagents Market Summary

The global oligonucleotide synthesis reagents market size was estimated at USD 723.3 million in 2025 and is projected to reach USD 1751.3 million by 2033, growing at a CAGR of 11.9% from 2026 to 2033. The growth is driven by increasing demand for oligonucleotide-based therapeutics, expanding applications in diagnostics and genomics, and advancements in DNA/RNA synthesis technologies.

Rapid growth of nucleic acid-based therapeutics

The rapid growth of nucleic acid-based therapeutics is a key driver of the oligonucleotide synthesis reagents market, as these therapies depend on synthetic oligonucleotides as core components. Modalities such as siRNA, antisense oligonucleotides (ASOs), CRISPR-based gene editing, and mRNA platforms are increasingly targeting previously undruggable pathways, with multiple approved therapies and a growing pipeline across oncology, rare genetic disorders, and infectious diseases. This expansion is driving demand for high-quality oligonucleotide production and, consequently, increasing consumption of synthesis reagents from research through commercialization.

Global Oligonucleotide Synthesis Reagents Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the oligonucleotide synthesis reagents market report based on product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Core synthesis reagents
  • Process reagents
  • Modification reagents
  • Purification-related reagents
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • PCR primers
  • PCR assays and panels
  • Sequencing
  • DNA microarrays
  • Fluorescence In Situ Hybridization (FISH)
  • Antisense oligonucleotides
  • Other applications
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic & research institutes
  • Diagnostic laboratories
  • Pharmaceutical and biotechnology companies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Oligonucleotide Synthesis Reagents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rapid growth of nucleic acid-based therapeutics
      • 3.2.1.2. Expansion of molecular diagnostics
      • 3.2.1.3. Advancements in synthesis technologies
      • 3.2.1.4. Expansion of genomics and genetic research
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of reagents and synthesis processes
      • 3.2.2.2. Complex and time-consuming synthesis procedures
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenge analysis
  • 3.3. Case Study Insights
  • 3.4. Oligonucleotide Synthesis Reagents Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTEL Analysis

Chapter 4. Oligonucleotide Synthesis Reagents Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Oligonucleotide Synthesis Reagents Market Product Movement Analysis
  • 4.3. Global Oligonucleotide Synthesis Reagents Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Core synthesis reagents
    • 4.4.1. Core synthesis reagents market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Process reagents
    • 4.5.1. Process reagents market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Modification reagents
    • 4.6.1. Modification reagents market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Purification-related reagents
    • 4.7.1. Purification-related reagents market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Oligonucleotide Synthesis Reagents Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Oligonucleotide Synthesis Reagents Market Application Movement Analysis
  • 5.3. Global Oligonucleotide Synthesis Reagents Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. PCR primers
    • 5.4.1. PCR primers market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. PCR assays and panels
    • 5.5.1. PCR assays and panels market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Sequencing
    • 5.6.1. Sequencing market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. DNA microarrays
    • 5.7.1. DNA microarrays market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Fluorescence In Situ Hybridization (FISH)
    • 5.8.1. Fluorescence In Situ Hybridization (FISH) market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.9. Antisense oligonucleotides
    • 5.9.1. Antisense oligonucleotides market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.10. Other applications
    • 5.10.1. Other applications market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Oligonucleotide Synthesis Reagents Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Oligonucleotide Synthesis Reagents Market End Use Movement Analysis
  • 6.3. Global Oligonucleotide Synthesis Reagents Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Academic & research institutes
    • 6.4.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Diagnostic laboratories
    • 6.5.1. Diagnostic laboratories market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Pharmaceutical and biotechnology companies
    • 6.6.1. Pharmaceutical and biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Oligonucleotide Synthesis Reagents Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory framework
      • 7.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory framework
      • 7.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Danaher Corporation
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Tokyo Chemical Industry Pvt. Ltd.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Agilent Technologies, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Bio-Synthesis, Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Kaneka Eurogentec S.A.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. LGC Biosearch Technologies
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Biolegio
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Twist Bioscience
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global oligonucleotide synthesis reagents market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America oligonucleotide synthesis reagents market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 9 North America oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 11 U.S. oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 12 U.S. oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe oligonucleotide synthesis reagents market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 23 Germany oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 24 Germany oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 25 Germany oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 26 UK oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 27 UK oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 28 UK oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 30 France oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 31 France oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 34 Italy oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 37 Spain oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 39 Denmark oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 40 Denmark oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 42 Sweden oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 43 Sweden oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 45 Norway oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 46 Norway oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific oligonucleotide synthesis reagents market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 52 China oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 53 China oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 55 Japan oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 56 Japan oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 58 India oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 59 India oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 64 Australia oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 65 Australia oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America oligonucleotide synthesis reagents market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 79 MEA oligonucleotide synthesis reagents market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 81 MEA oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 82 MEA oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait oligonucleotide synthesis reagents market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait oligonucleotide synthesis reagents market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait oligonucleotide synthesis reagents market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Oligonucleotide synthesis reagents market: Market outlook
  • Fig. 5 Oligonucleotide synthesis reagents market: Segment outlook
  • Fig. 6 Oligonucleotide synthesis reagents market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Oligonucleotide synthesis reagents market driver impact
  • Fig. 9 Oligonucleotide synthesis reagents market restraint impact
  • Fig. 10 Oligonucleotide synthesis reagents market: Product outlook and key takeaways
  • Fig. 11 Oligonucleotide synthesis reagents market: Product movement analysis
  • Fig. 12 Core synthesis reagents market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 13 Process reagents market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 14 Modification reagents market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 15 Purification-related reagents market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 16 Others market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 17 Oligonucleotide synthesis reagents market: Application outlook and key takeaways
  • Fig. 18 Oligonucleotide synthesis reagents market: Application movement analysis
  • Fig. 19 PCR primers market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 20 PCR assays and panels market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 21 Sequencing market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 22 DNA microarrays market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 23 Fluorescence In Situ Hybridization (FISH) market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 24 Antisense oligonucleotides market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 25 Other applications market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 26 Oligonucleotide synthesis reagents market: End use outlook and key takeaways
  • Fig. 27 Oligonucleotide synthesis reagents market: End use movement analysis market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 28 Academic & research institutes market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 29 Diagnostic laboratories market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 30 Pharmaceutical and biotechnology companies market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 31 Global oligonucleotide synthesis reagents market: Regional outlook and key takeaways
  • Fig. 32 Global oligonucleotide synthesis reagents market: Regional movement analysis
  • Fig. 33 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Key country
  • Fig. 37 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)